首页
热心肠日报
文献库
产业库
榜单
关于日报
《肠·道》演讲
往期精彩
《肠·道》2024
《肠·道》2023
《肠·道》2022
《肠·道》2021
《肠·道》2020
《肠·道》2019
《肠·道》2018
《肠·道》2017
关于《肠·道》
肠道大会
热心肠大会
热心肠智库
智库专家
专家动态
智库新闻
关于智库
奖学金
年度人物奖
更多
HOPE
会议信息
科学与艺术
学术专刊
R·AI
周刊
热心肠先生
研究院动态
关于我们
搜索
登录
关闭
手机邮箱登录
扫码登录
微信扫描二维码快捷登录
验证成功，将在
3
秒钟后跳转
已超时，请
重试
关闭
二维码登录
手机登录
邮箱登录
+86
+1
+852
+886
+81
+65
+61
+44
获取验证码
登录 / 注册
关闭
二维码登录
手机登录
邮箱登录
获取验证码
登录 / 注册
热心肠智库
专家文章 | 陈启仪
2024
CA
Donor-recipient intermicrobial interactions impact transfer of subspecies and fecal microbiota transplantation outcome
Cell Host Microbe, 10.1016/j.chom.2024.01.013
2023
CA
Regional homogeneity alterations in patients with functional constipation and their associations with gene expression profiles
CEREB CORTEX, 10.1093/cercor/bhad403
CA
SA
Depletion of butyrate-producing microbes of the Firmicutes predicts nonresponse to FMT therapy in patients with recurrent Clostridium difficile infection
Gut Microbes, 10.1080/19490976.2023.2236362
点击查看热心肠日报解读
CA
SA
Depletion of butyrate-producing microbes of the Firmicutes predicts nonresponse to FMT therapy in patients with recurrent Clostridium difficile infection
Gut Microbes, 10.1080/19490976.2023.2236362
点击查看热心肠日报解读
CA
SA
Depletion of butyrate-producing microbes of the Firmicutes predicts nonresponse to FMT therapy in patients with recurrent Clostridium difficile infection
Gut Microbes, 10.1080/19490976.2023.2236362
点击查看热心肠日报解读
CA
Depletion of butyrate-producing microbes of the Firmicutes predicts nonresponse to FMT therapy in patients with recurrent Clostridium difficile infection
Gut Microbes, 10.1080/19490976.2023.2236362
点击查看热心肠日报解读
2022
CA
Long-term safety of faecal microbiota transplantation for gastrointestinal diseases in China
LANCET GASTROENTEROL, 10.1016/S2468-1253(22)00170-4
点击查看热心肠日报解读
CA
FTACMT study protocol: a multicentre, double-blind, randomised, placebo-controlled trial of faecal microbiota transplantation for autism spectrum disorder
BMJ Open, 10.1136/bmjopen-2021-051613
2021
CA
Enteral nutrition ameliorates the symptoms of Crohn's disease in mice via activating special pro-resolving mediators through innate lymphoid cells
Innate Immun, 10.1177/17534259211057038
CA
Donor Screening for Fecal Microbiota Transplantation in China: Evaluation of 8483 Candidates
Gastroenterology, 10.1053/j.gastro.2021.11.004
点击查看热心肠日报解读
CA
The Efficacy and Safety of Fecal Microbiota Transplantation Combined With Biofeedback for Mixed Constipation: A Retrospective Cohort Study
FRONT MED-LAUSANNE, 10.3389/fmed.2021.746990
点击查看热心肠日报解读
CA
Fecal Microbiota Transplantation Modulates the Gut Flora Favoring Patients With Functional Constipation
FMICB, 10.3389/fmicb.2021.700718
